These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Self-Assembling Peptides Form Immune Suppressive Amyloid Fibrils Effective in Autoimmune Encephalomyelitis. Kurnellas MP; Rothbard JB; Steinman L Curr Top Behav Neurosci; 2015; 26():221-32. PubMed ID: 25981913 [TBL] [Abstract][Full Text] [Related]
4. An amyloidogenic hexapeptide derived from amylin attenuates inflammation and acute lung injury in murine sepsis. Mahapatra S; Ying L; Ho PP; Kurnellas M; Rothbard J; Steinman L; Cornfield DN PLoS One; 2018; 13(7):e0199206. PubMed ID: 29990318 [TBL] [Abstract][Full Text] [Related]
5. Reversal of paralysis and reduced inflammation from peripheral administration of β-amyloid in TH1 and TH17 versions of experimental autoimmune encephalomyelitis. Grant JL; Ghosn EE; Axtell RC; Herges K; Kuipers HF; Woodling NS; Andreasson K; Herzenberg LA; Herzenberg LA; Steinman L Sci Transl Med; 2012 Aug; 4(145):145ra105. PubMed ID: 22855462 [TBL] [Abstract][Full Text] [Related]
6. Neurological Disease as a Failure of Brain-Immune Crosstalk: The Multiple Faces of Neuroinflammation. Schwartz M; Deczkowska A Trends Immunol; 2016 Oct; 37(10):668-679. PubMed ID: 27616557 [TBL] [Abstract][Full Text] [Related]
7. Peripheral Tumor Necrosis Factor-Alpha (TNF-α) Modulates Amyloid Pathology by Regulating Blood-Derived Immune Cells and Glial Response in the Brain of AD/TNF Transgenic Mice. Paouri E; Tzara O; Kartalou GI; Zenelak S; Georgopoulos S J Neurosci; 2017 May; 37(20):5155-5171. PubMed ID: 28442538 [TBL] [Abstract][Full Text] [Related]
8. Ageing and recurrent episodes of neuroinflammation promote progressive experimental autoimmune encephalomyelitis in Biozzi ABH mice. Peferoen LA; Breur M; van de Berg S; Peferoen-Baert R; Boddeke EH; van der Valk P; Pryce G; van Noort JM; Baker D; Amor S Immunology; 2016 Oct; 149(2):146-56. PubMed ID: 27388634 [TBL] [Abstract][Full Text] [Related]
9. Pentraxin-3 is upregulated in the central nervous system during MS and EAE, but does not modulate experimental neurological disease. Ummenthum K; Peferoen LA; Finardi A; Baker D; Pryce G; Mantovani A; Bsibsi M; Bottazzi B; Peferoen-Baert R; van der Valk P; Garlanda C; Kipp M; Furlan R; van Noort JM; Amor S Eur J Immunol; 2016 Mar; 46(3):701-11. PubMed ID: 26576501 [TBL] [Abstract][Full Text] [Related]
11. Platelets in Multiple Sclerosis: Early and Central Mediators of Inflammation and Neurodegeneration and Attractive Targets for Molecular Imaging and Site-Directed Therapy. Orian JM; D'Souza CS; Kocovski P; Krippner G; Hale MW; Wang X; Peter K Front Immunol; 2021; 12():620963. PubMed ID: 33679764 [TBL] [Abstract][Full Text] [Related]
12. Minocycline alleviates beta-amyloid protein and tau pathology via restraining neuroinflammation induced by diabetic metabolic disorder. Cai Z; Yan Y; Wang Y Clin Interv Aging; 2013; 8():1089-95. PubMed ID: 23983461 [TBL] [Abstract][Full Text] [Related]
13. Introduction to a special issue on cytokines in neuroinflammation and immunity. Dhib-Jalbut S; Kalvakolanu DV J Interferon Cytokine Res; 2014 Aug; 34(8):557-8. PubMed ID: 25084172 [No Abstract] [Full Text] [Related]
14. Activation of Glucagon-Like Peptide-1 Receptor Promotes Neuroprotection in Experimental Autoimmune Encephalomyelitis by Reducing Neuroinflammatory Responses. Lee CH; Jeon SJ; Cho KS; Moon E; Sapkota A; Jun HS; Ryu JH; Choi JW Mol Neurobiol; 2018 Apr; 55(4):3007-3020. PubMed ID: 28456941 [TBL] [Abstract][Full Text] [Related]
15. HIV-1 Tat protein attenuates the clinical course of experimental autoimmune encephalomyelitis (EAE). Karampoor S; Zahednasab H; Bokharaei-Salim F; Mirzaei R; Mojallal-Tabatabaei Z; Esghaei M; Keyvani H Int Immunopharmacol; 2020 Jan; 78():105943. PubMed ID: 31830622 [TBL] [Abstract][Full Text] [Related]
16. Amyloids in Site-Specific Autoimmune Reactions and Inflammatory Responses. Huang YM; Hong XZ; Shen J; Geng LJ; Pan YH; Ling W; Zhao HL Front Immunol; 2019; 10():2980. PubMed ID: 31993048 [TBL] [Abstract][Full Text] [Related]
17. Emerging role of IL-16 in cytokine-mediated regulation of multiple sclerosis. Skundric DS; Cruikshank WW; Montgomery PC; Lisak RP; Tse HY Cytokine; 2015 Oct; 75(2):234-48. PubMed ID: 25703787 [TBL] [Abstract][Full Text] [Related]
18. Adenosine A2A Receptor Signaling in the Immunopathogenesis of Experimental Autoimmune Encephalomyelitis. Rajasundaram S Front Immunol; 2018; 9():402. PubMed ID: 29559972 [TBL] [Abstract][Full Text] [Related]
19. Genetic background modulates outcome of therapeutic amyloid peptides in treatment of neuroinflammation. Kraus A; Race B; Phillips K; Winkler C; Saturday G; Kurnellas M; Rothbard JB; Groveman BR; Steinman L; Caughey B J Neuroimmunol; 2016 Sep; 298():42-50. PubMed ID: 27609274 [TBL] [Abstract][Full Text] [Related]
20. Th17 cell, the new player of neuroinflammatory process in multiple sclerosis. Jadidi-Niaragh F; Mirshafiey A Scand J Immunol; 2011 Jul; 74(1):1-13. PubMed ID: 21338381 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]